HVIVO.COM: Keyword Density Checker

Total words: 2858 | 2-word phrases: 753 | 3-word phrases: 833 | 4-word phrases: 853

PAGE INFO

Title	Try to keep the title under 60 characters (66 characters) hVIVO \| World Leader in Challenge Trials & Laboratory Services
Description	Try to keep the meta description between 50 - 160 characters (139 characters) We at hVIVO are the industry leader in full-service viral challenge studies. Learn about our challenge models, lab services, and more here.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (56 characters) World leader in challenge trials and laboratory services

#	Keyword	Frequency	Density
1	human challenge trials	3	0.36%
2	about us about	2	0.24%
3	icon start date	2	0.24%
4	marker icon location	2	0.24%
5	infants the elderly	2	0.24%
6	map marker icon	2	0.24%
7	2024 map marker	2	0.24%
8	results centre share	2	0.24%
9	alerts results centre	2	0.24%
10	newsemail alerts results	2	0.24%
11	regulatory newsemail alerts	2	0.24%
12	calendar icon start	2	0.24%
13	oct 2024 map	2	0.24%
14	world leader in	2	0.24%
15	oct 2024 calendar	2	0.24%
16	2024 calendar icon	2	0.24%
17	hvivo can help	2	0.24%
18	media press kit	2	0.24%
19	challenge trials hlab	2	0.24%
20	coverage media press	2	0.24%
21	media coverage media	2	0.24%
22	human challenge model	2	0.24%
23	calendar icon end	2	0.24%
24	hvivo services limited	2	0.24%
25	aim rule 26	2	0.24%
26	phase iiiii trials	2	0.24%
27	scroll for more	2	0.24%
28	are the most	1	0.12%
29	prophylactics and therapeutics	1	0.12%
30	both prophylactics and	1	0.12%

#	Keyword	Frequency	Density
1	regulatory newsemail alerts results	2	0.23%
2	newsemail alerts results centre	2	0.23%
3	2024 map marker icon	2	0.23%
4	oct 2024 map marker	2	0.23%
5	alerts results centre share	2	0.23%
6	map marker icon location	2	0.23%
7	oct 2024 calendar icon	2	0.23%
8	2024 calendar icon end	2	0.23%
9	media coverage media press	2	0.23%
10	coverage media press kit	2	0.23%
11	calendar icon start date	2	0.23%
12	symptoms normally involved usually	1	0.12%
13	us about hvivo leadership	1	0.12%
14	mirror those of the	1	0.12%
15	normally involved usually mirror	1	0.12%
16	involved usually mirror those	1	0.12%
17	usually mirror those of	1	0.12%
18	through close contact the	1	0.12%
19	those of the common	1	0.12%
20	of the common cold	1	0.12%
21	calendar icon end date	1	0.12%
22	to person through close	1	0.12%
23	person through close contact	1	0.12%
24	first identified in 2001	1	0.12%
25	product learn more hmpv	1	0.12%
26	19 oct 2024 map	1	0.12%
27	human metapneumovirus hmpv was	1	0.12%
28	metapneumovirus hmpv was first	1	0.12%
29	hmpv was first identified	1	0.12%
30	was first identified in	1	0.12%
31	identified in 2001 and	1	0.12%
32	date 16 oct 2024	1	0.12%
33	in 2001 and is	1	0.12%
34	2001 and is a	1	0.12%
35	date 19 oct 2024	1	0.12%
36	disease that spreads person	1	0.12%
37	that spreads person to	1	0.12%
38	spreads person to person	1	0.12%
39	person to person through	1	0.12%
40	16 oct 2024 calendar	1	0.12%

#	URL	Whois	Check
1	https://www.linkedin.com/company/hvivo/	Whois	linkedin.com
2	https://twitter.com/hVIVO_UK	Whois	twitter.com
3	https://www.londonstockexchange.com/news-article/HVO/plans-for-a-new-larger-state-of-the-art-facility/16100143	Whois	londonstockexchange.com
4	https://hlabservices.com/	Whois	hlabservices.com
5	https://idweek.org/registration/	Whois	idweek.org
6	https://www.terrapinn.com/conference/world-vaccine-congress-europe/index.stm	Whois	terrapinn.com
7	https://hlabservices.com/	Whois	hlabservices.com
8	https://www.nephew.media/	Whois	nephew.media
9	https://www.linkedin.com/company/hvivo/	Whois	linkedin.com
10	https://twitter.com/hVIVO_UK	Whois	twitter.com